Moving away from amyloid beta to move on in Alzheimer research

Frontiers in Aging Neuroscience

Volumn 7, Issue JAN, 2015, Pages

  Moreno Treviño, María G ^a   Castillo López, Jesús ^a   Meester, Irene ^a  

^a UNIVERSIDAD DE MONTERREY   (Mexico)

Author keywords

Alzheimer's disease; Amyloid beta; Bioenergetics; Etiology; Herpes simplex type 1

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; GAMMA SECRETASE; OLIGOMER; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL COUNTING; COGNITIVE RESERVE; GENETIC ASSOCIATION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HISTOPATHOLOGY; HUMAN; MEDICAL RESEARCH; NEUROFIBRILLARY TANGLE; NONHUMAN; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; SENILE PLAQUE; VIRUS PATHOGENESIS;

EID: 84922437629     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00002     Document Type: Article

References (53)

1. Alzheimer's Association. (2014). 2014 Alzheimer's disease facts and figures. Alzheimers Dement. 10, e47-e92. doi:10.1016/j.jalz.2014.02.001
2. Armien, A. G., Hu, S., Little, M. R., Robinson, N., Lokensgard, J. R., Low, W. C., et al. (2010). Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis. Brain Pathol. 20, 738-750. doi:10.1111/j.1750-3639.2009.00354.x
3. Ball, M. J., Lukiw, W. J., Kammerman, E. M., and Hill, J. M. (2013). Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology. Alzheimers Dement. 9, 169-175. doi:10.1016/j.jalz.2012.07.005
4. Bell, R. D., and Zlokovic, B. V. (2009). Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 118, 103-113. doi:10.1007/s00401-009-0522-3
5. Boyd-Kimball, D., Sultana, R., Poon, H. F., Lynn, B. C., Casamenti, F., Pepeu, G., et al. (2005). Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience 132, 313-324. doi:10.1016/j.neuroscience.2004.12.022
6. Braak, H., and Del Tredici, K. (2011). Alzheimer's pathogenesis: is there neuron-to-neuron propagation? Acta Neuropathol. 121, 589-595. doi:10.1007/s00401-011-0825-z
7. Burgos, J. S., Ramirez, C., Sastre, I., and Valdivieso, F. (2006). Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA. J. Virol. 80, 5383-5387. doi:10.1128/JVI.00006-06
8. Busciglio, J., Lorenzo, A., Yeh, J., and Yankner, B. A. (1995). Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888. doi:10.1016/0896-6273(95)90232-5
9. Camandola, S., and Mattson, M. P. (2011). Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. Biochim. Biophys. Acta 1813, 965-973. doi:10.1016/j.bbamcr.2010.10.005
10. Carter, C. J. (2008). Interactions between the products of the herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades. Neurochem. Int. 52, 920-934. doi:10.1016/j.neuint.2007.11.003
11. Chang, K. A., Kim, H. S., Ha, T. Y., Ha, J. W., Shin, K. Y., Jeong, Y. H., et al. (2006). Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol. Cell. Biol. 26, 4327-4338. doi:10.1128/MCB.02393-05
12. Cugini, C., Klepac-Ceraj, V., Rackaityte, E., Riggs, J. E., and Davey, M. E. (2013). Porphyromonas gingivalis: keeping the pathos out of the biont. J. Oral. Microbiol. 5:19804. doi:10.3402/jom.v5i0.19804
13. Cummings, J. L., Ringman, J., and Vinters, H. V. (2014). Neuropathologic correlates of trial-related instruments for Alzheimer's disease. Am. J. Neurodegener. Dis. 3, 45-49. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986610/pdf/ajnd0003-0045.pdf
14. D'Andrea, M. R. (2003). Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res. 982, 19-30. doi:10.1016/S0006-8993(03)02881-6
15. de la Torre, J. C. (2002). Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33, 1152-1162. doi:10.1161/01.STR.0000014421.15948.67
16. Di Paolo, G., and Kim, T. W. (2011). Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 12, 284-296. doi:10.1038/nrn3012
17. Geerts, H., Roberts, P., Spiros, A., and Carr, R. (2013). A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's disease. Front Pharmacol. 4:47. doi:10.3389/fphar.2013.00047
18. Geiss, B. J., Cano, G. L., Tavis, J. E., and Morrison, L. A. (2004). Herpes simplex virus 2 VP22 phosphorylation induced by cellular and viral kinases does not influence intracellular localization. Virology 330, 74-81. doi:10.1016/j.virol.2004.08.034
19. Ghosal, K., Vogt, D. L., Liang, M., Shen, Y., Lamb, B. T., and Pimplikar, S. W. (2009). Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc. Natl. Acad. Sci. U. S. A. 106, 18367-18372. doi:10.1073/pnas.0907652106
20. Grimm, A., Schmitt, K., Lang, U. E., Mensah-Nyagan, A. G., and Eckert, A. (2014). Improvement of neuronal bioenergetics by neurosteroids: implications for age-related neurodegenerative disorders. Biochim. Biophys. Acta. 1842, 2427-2438. doi:10.1016/j.bbadis.2014.09.013
21. Haass, C., Kaether, C., Thinakaran, G., and Sisodia, S. (2012). Trafficking and proteolytic processing of APP. Cold. Spring. Harb. Perspect. Med. 2, a006270. doi:10.1101/cshperspect.a006270
22. Hampel, H., Burger, K., Teipel, S. J., Bokde, A. L., Zetterberg, H., and Blennow, K. (2008). Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement. 4, 38-48. doi:10.1016/j.jalz.2007.08.006
23. Hardy, J. A., and Higgins, G. A. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185. doi:10.1126/science.1566067
24. Hill, J. M., Clement, C., Pogue, A. I., Bhattacharjee, S., Zhao, Y., and Lukiw, W. J. (2014). Pathogenic microbes, the microbiome, and Alzheimer's disease (AD). Front. Aging Neurosci. 6:127. doi:10.3389/fnagi.2014.00127
25. Hommet, C., Mondon, K., Constans, T., Beaufils, E., Desmidt, T., Camus, V., et al. (2011). Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds. Dement. Geriatr. Cogn. Disord. 32, 367-378. doi:10.1159/000335568
26. Itzhaki, R. F. (2014). Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus. Front. Aging Neurosci. 6:202. doi:10.3389/fnagi.2014.00202
27. Jellinger, K. A., and Bancher, C. (1998). Neuropathology of Alzheimer's disease: a critical update. J. Neural Transm. Suppl. 54, 77-95. doi:10.1007/978-3-7091-7508-8_8
28. Jucker, M., and Walker, L. C. (2011). Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann. Neurol. 70, 532-540. doi:10.1002/ana.22615
29. Kandiah, N., Chander, R. J., Ng, A., Wen, M. C., Cenina, A. R., and Assam, P. N. (2015). Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease. Eur. J. Neurol. 22, 150-155. doi:10.1111/ene.12546
30. Kettenmann, H., Hanisch, U. K., Noda, M., and Verkhratsky, A. (2011). Physiology of microblia. Physiol. Rev. 91, 461-553. doi:10.1152/physrev.0011.2010
31. Letenneur, L., Peres, K., Fleury, H., Garrigue, I., Barberger-Gateau, P., Helmer, C., et al. (2008). Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS ONE 3:e3637. doi:10.1371/journal.pone.0003637
32. Lurain, N. S., Hanson, B. A., Martinson, J., Leurgans, S. E., Landay, A. L., Bennett, D. A., et al. (2013). Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J. Infect. Dis. 208, 564-572. doi:10.1093/infdis/jit210
33. Marshall, B. J., and Warren, J. R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311-1315. doi:10.1016/S0140-6736(84)91816-6
34. Mattson, M. P. (2010). ER calcium and Alzheimer's disease: in a state of flux. Sci. Signal. 3, e10. doi:10.1126/scisignal.3114pe10
35. McGeer, P. L., and McGeer, E. G. (2013). The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol. 126, 479-497. doi:10.1007/s00401-013-1177-7
36. Morris, G. P., Clark, I. A., and Vissel, B. (2014). Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. Acta. Neuropathol. Commun. 2, 135. doi:10.1186/s40478-014-0135-5
37. Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., et al. (2012). Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J. Neuropathol. Exp. Neurol. 71, 362-381. doi:10.1097/NEN.0b013e31825018f7
38. Oberheim, N. A., Goldman, S. A., and Nedergaard, M. (2012). Heterogeneity of astrocytic form and function. Methods Mol. Biol. 814, 23-45. doi:10.1007/978-1-61779-452-0_3
39. Ohara, P. T., Chin, M. S., and LaVail, J. H. (2000). The spread of herpes simplex virus type 1 from trigeminal neurons to the murine cornea: an immunoelectron microscopy study. J. Virol. 74, 4776-4786. doi:10.1128/JVI.74.10.4776-4786.2000
40. Pelvig, D. P., Pakkenberg, H., Regeur, L., Oster, S., and Pakkenberg, B. (2003). Neocortical glial cell numbers in Alzheimer's disease. A stereological study. Dement. Geriatr. Cogn. Disord. 16, 212-219. doi:10.1159/000072805
41. Pentreath, V. W., and Mead, C. (2004). Responses of cultured astrocytes, c6 glioma and 1321NI astrocytoma cells to amyloid beta-peptide fragments. Nonlinearity Biol. Toxicol. Med. 2, 45-63. doi:10.1080/15401420490426990
42. Piacentini, R., De Chiara, G., Li Puma, D. D., Ripoli, C., Marcocci, M. E., Garaci, E., et al. (2014). HSV-1 and Alzheimer's disease: more than a hypothesis. Front Pharmacol. 5:97. doi:10.3389/fphar.2014.00097
43. Price, J. L., and Morris, J. C. (1999). Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann. Neurol. 45, 358-368. doi:10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X
44. Roher, A. E., Palmer, K. C., Capodilupo, J., Wakade, A. R., and Ball, M. J. (1991). New biochemical insights to unravel the pathogenesis of Alzheimer's lesions. Can. J. Neurol. Sci. 18(Suppl.), 408-410.
45. Scheibel, A. B., Duong, T. H., and Jacobs, R. (1989). Alzheimer's disease as a capillary dementia. Ann. Med. 21, 103-107. doi:10.3109/07853898909149194
46. Selkoe, D. J. (2008). Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106-113. doi:10.1016/j.bbr.2008.02.016
47. Smith, J. S., and Robinson, N. J. (2002). Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 186(Suppl. 1), S3-S28. doi:10.1086/343739
48. Sorensen, A. A. (2009). Alzheimer's disease research: scientific productivity and impact of the top 100 investigators in the field. J. Alzheimers Dis. 16, 451-465. doi:10.3233/JAD-2009-1046
49. Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 11, 1006-1012. doi:10.1016/S1474-4422(12)70191-6
50. Valeski, J. E., Kumar, V., Beutner, E. H., Cartone, C., and Kasprzyk, K. (1992). Differentiation of bullous pemphigoid from epidermolysis bullosa acquisita on frozen skin biopsies. Int. J. Dermatol. 31, 37-41. doi:10.1111/j.1365-4362.1992.tb03518.x
51. Wang, B., Wang, Z., Sun, L., Yang, L., Li, H., Cole, A. L., et al. (2014). The amyloid precursor protein controls adult hippocampal neurogenesis through GABAergic interneurons. J. Neurosci. 34, 13314-13325. doi:10.1523/JNEUROSCI.2848-14.2014
52. Wisner, T. W., Sugimoto, K., Howard, P. W., Kawaguchi, Y., and Johnson, D. C. (2011). Anterograde transport of herpes simplex virus capsids in neurons by both separate and married mechanisms. J. Virol. 85, 5919-5928. doi:10.1128/JVI.00116-11
53. Yao, J., and Brinton, R. D. (2012). Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease. Adv. Pharmacol. 64, 327-371. doi:10.1016/B978-0-12-394816-8.00010-6